Government News

The U.S. Food and Drug Administration issued an emergency use authorization for a blood purification system to treat patients 18 years of age or older with confirmed Coronavirus Disease 2019 (COVID-19) admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure.

There will not be any shortage of hydroxychloroquine in the country either today or in the future. Community support plays an important role in helping to identify cases early which in turn is key to containing spread and mortality due to COVID-19. States have started providing assistance to building and construction sector workers, as per the component under Rs. 1.7 lakh crore Pradhan Mantri Garib Kalyan Yojana package : Union Home Affairs Ministry.

Three classes of facilities to be set up for various categories of COVID-19 patients: Health Ministry’s guidance document for managing COVID-19, Government strategy for cluster containment and for managing outbreaks yielding positive results in some areas : Union Health Ministry

Supply lines from abroad opened up today with the receipt of 1.70 lakh Personal Protection Equipment (PPE) coveralls from China which have been donated to the Government of India. Along with domestic supplies of 20,000 coveralls, a total of 1.90 lakh coveralls will now be distributed to hospitals and will add to the 3,87,473 PPEs already available in the country as of now. A total of 2.94 lakh PPE coveralls have been arranged and supplied by Government of India now.

Hydroxychloroquine is taken under schedule H1 of Drugs and Cosmetics rules by central government to prevent  misuse and regulate sales of hydroxychloroquine. Hydroxychloroquine is anti-malarial medicine and known to have certain effects on novel corona virus infection (COVID-19) as per clinical trials.